help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on November 4, 2005, doi:10.1164/rccm.200506-917OC

Am. J. Respir. Crit. Care Med., Volume 173, Number 3, February 2006, 288-296

A more recent version of this article appeared on February 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200506-917OCv1
173/3/288    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Heeckeren, A. M
Right arrow Articles by Davis, P. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Heeckeren, A. M
Right arrow Articles by Davis, P. B

Submitted on June 14, 2005
Accepted on November 1, 2005

Response to Acute Lung Infection with Mucoid Pseudomonas aeruginosa in Cystic Fibrosis Mice

Anna M van Heeckeren1*, Mark D Schluchter1, Wei Xue1, and Pamela B Davis1

1 Department of Pediatrics, Case Western Reserve University School of Medicine, Rainbow Babies and Childrens Hospital, Cleveland, OH, USA

* To whom correspondence should be addressed. E-mail: anna.vanheeckeren{at}case.edu.

Rationale: Cystic fibrosis is caused by defects in the cystic fibrosis transmembrane conductance regulator gene which codes for a chloride channel, but the role of this chloride channel in inflammation induced by lung infection with Pseudomonas aeruginosa remains to be defined. Objectives: We tested the hypothesis that loss of this chloride channel alone is sufficient to cause excessive inflammation in response to inflammatory stimuli. Methods: We investigated the response of cystic fibrosis and wild type mice to mucoid P. aeruginosa administered by insufflation. Measurements: The host responses measured included survival, weight change, lung morphometry, bacterial clearance, and inflammatory mediators and cell counts were assessed in bronchoalveolar lavage fluid. Main Results: Depending on the dose administered and frequency of dosing, cystic fibrosis mice experienced significantly higher mortality rates, greater weight loss, higher lung pathology scores, and higher inflammatory mediator and neutrophil levels compared to wild type mice, even after the bacteria had been cleared. Surprisingly, bacteria were cleared just as rapidly in cystic fibrosis mice as in wild type mice, and sepsis was not observed. Chronic lung infections could not be established with mucoid P. aeruginosa in either cystic fibrosis or wild type mice. Conclusions: Absence of this chloride channel alone appears sufficient for exaggerated inflammation and excess mortality compared to wild type controls in the face of mucoid P. aeruginosa lung infection. To establish chronic infection, additional factors such as bacterial trapping or poor clearance may be required.
Key words: cystic fibrosis, inflammation, pathogenesis, cystic fibrosis transmembrane conductance regulator




This article has been cited by other articles:


Home page
 Lab AnimHome page
I Kukavica-Ibrulj and R C Levesque
Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies
Lab Anim, October 1, 2008; 42(4): 389 - 412.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Perez, A. M. van Heeckeren, D. Nichols, S. Gupta, J. F. Eastman, and P. B. Davis
Peroxisome proliferator-activated receptor-{gamma} in cystic fibrosis lung epithelium
Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L303 - L313.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. Benarafa, G. P. Priebe, and E. Remold-O'Donnell
The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection
J. Exp. Med., August 6, 2007; 204(8): 1901 - 1909.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
A. Saadane, S. Masters, J. DiDonato, J. Li, and M. Berger
Parthenolide Inhibits I{kappa}B Kinase, NF-{kappa}B Activation, and Inflammatory Response in Cystic Fibrosis Cells and Mice
Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 728 - 736.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. C. Dechecchi, E. Nicolis, V. Bezzerri, A. Vella, M. Colombatti, B. M. Assael, Y. Mettey, M. Borgatti, I. Mancini, R. Gambari, et al.
MPB-07 Reduces the Inflammatory Response to Pseudomonas aeruginosa in Cystic Fibrosis Bronchial Cells
Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 615 - 624.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. J. Accurso
Update in Cystic Fibrosis 2006
Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 754 - 757.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. Reiniger, M. M. Lee, F. T. Coleman, C. Ray, D. E. Golan, and G. B. Pier
Resistance to Pseudomonas aeruginosa Chronic Lung Infection Requires Cystic Fibrosis Transmembrane Conductance Regulator-Modulated Interleukin-1 (IL-1) Release and Signaling through the IL-1 Receptor
Infect. Immun., April 1, 2007; 75(4): 1598 - 1608.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. J. Dubin and J. K. Kolls
IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L519 - L528.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. Guilbault, Z. Saeed, G. P. Downey, and D. Radzioch
Cystic Fibrosis Mouse Models
Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 1 - 7.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society 		  2009 ATS Conference Fees